STOCK COMPENSATION PLANS (Tables)

9 Months Ended

Aug. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of the status of stock options granted by MultiCell at August 31, 2014, and changes during the nine months then ended is presented in the following table:

					Weighted
			Weighted		Average
	Shares		Average		Remaining		Aggregate
	Under		Exercise		Contractual		Intrinsic
	Option		Price		Life		Value
Outstanding at November 30, 2013		50,399,503	$	0.0040		3.7 years	$	-
Granted		25,074,710		0.0008
Exercised		-		-
Expired or forfeited		(4,030,000)		0.0110
Outstanding at August 31, 2014		71,444,213	$	0.0025		3.6 years	$	-
Exercisable at August 31, 2014		54,300,697	$	0.0030		3.4 years	$	-

Xenogenics Corporation [Member]

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of the status of Xenogenics’ stock options at August 31, 2014, and changes during the nine months then ended is presented in the following table:

					Weighted
			Weighted		Average
	Shares		Average		Remaining
	Under		Exercise		Contractual
	Option		Price		Life
Outstanding at November 30, 2013		4,250,000	$	0.246		2.3 years
Granted		-	$	-
Exercised		-	$	-
Expired or forfeited		(3,000,000)	$	0.246
Outstanding at August 31, 2014		1,250,000	$	0.246		2.4 years
Exercisable at August 31, 2014		1,250,000	$	0.246		2.4 years